| Column 1 | Column 2 |
Item | Disease | Employment |
Infectious diseases | |
1 | Anthrax | Employment involving work with: (a) animals; or (b) animal carcasses; or (c) animal parts. |
2 | Brucellosis | Employment involving work with: (a) animals; or (b) animal carcasses; or (c) animal parts; or (d) animal waste. |
3 | Hepatitis A | Employment involving work with human waste. |
4 | Hepatitis B or Hepatitis C | Employment involving work with human body fluids. |
5 | Human Immunodeficiency Virus (HIV) or Acquired Immune Deficiency Syndrome (AIDS) | Employment involving work with: (a) needles in a healthcare services setting; or (b) sharps in a healthcare services setting. |
6 | Leptospirosis | Employment involving work with: (a) animals; or (b) animal carcasses; or (c) animal parts; or (d) animal waste. |
7 | Orf | Employment involving work with: (a) goats; or (b) goat carcasses; or (c) sheep; or (d) sheep carcasses. |
8 | Q-fever | Employment involving work with: (a) animals; or (b) animal carcasses; or (c) animal parts. |
9 | Tuberculosis | Employment involving work with: (a) animals: (i) in a farming setting; or (ii) in a veterinarian setting; or (b) animal carcasses: (i) in a farming setting; or (ii) in a veterinarian setting; or (c) human corpses: (i) in a healthcare services setting; or (ii) in a mortuary setting; or (d) persons (individuals) in a healthcare services setting. |
Malignant diseases |
10 | Primary malignant disease of the salivary gland | Employment for at least 5 years (whether consecutive or not) involving work with: (a) equipment that produces ionising radiation; or (b) substances that emit ionising radiation. |
11 | Primary malignant disease of the nasopharynx | Employment for at least 5 years (whether consecutive or not) involving work with: (a) formaldehyde; or (b) wood. |
12 | Primary malignant disease of the oesophagus | Employment for at least 5 years (whether consecutive or not) involving work with: (a) equipment that produces ionising radiation; or (b) substances that emit ionising radiation. |
13 | Primary malignant disease of the stomach | Employment for at least 5 years (whether consecutive or not) involving work with: (a) equipment that produces ionising radiation; or (b) substances that emit ionising radiation. |
14 | Primary malignant disease of the colon or rectum | Employment for at least 5 years (whether consecutive or not) involving work with: (a) equipment that produces ionising radiation; or (b) substances that emit ionising radiation. |
15 | Primary malignant disease of the liver | Employment for at least 5 years (whether consecutive or not) involving work with vinyl chloride monomer. |
16 | Primary malignant disease of the nasal cavity or para-nasal sinuses | Employment for at least 5 years (whether consecutive or not) involving work with: (a) equipment that produces ionising radiation; or (b) substances that emit ionising radiation; or (c) nickel; or (d) leather; or (e) wood. |
17 | Primary malignant disease of the larynx | Employment for at least 5 years (whether consecutive or not) involving work with: (a) asbestos; or (b) asbestos-containing material; or (c) acid mist (strong inorganic). |
18 | Primary malignant disease of the lung caused by asbestos | Employment for at least 5 years (whether consecutive or not) involving work with: (a) asbestos; or (b) asbestos-containing material. |
19 | Primary malignant disease of the bone | Employment for at least 5 years (whether consecutive or not) involving work with: (a) equipment that produces ionising radiation; or (b) substances that emit ionising radiation. |
20 | Primary malignant disease of the mesothelium | Employment for at least one year (whether consecutive or not) involving work with: (a) asbestos; or (b) asbestos-containing material. |
21 | Primary malignant disease of the breast | Employment for at least 5 years (whether consecutive or not) involving work with: (a) equipment that produces ionising radiation; or (b) substances that emit ionising radiation. |
22 | Primary malignant disease of the ovary | Employment for at least 5 years (whether consecutive or not) involving work with: (a) asbestos; or (b) asbestos-containing material. |
23 | Primary malignant disease of the kidney | Employment for at least 5 years (whether consecutive or not) involving work with: (a) equipment that produces ionising radiation; or (b) substances that emit ionising radiation; or (c) trichloroethylene. |
24 | Primary malignant disease of urothelial tissue lining the urinary tract | Employment for at least 5 years (whether consecutive or not) involving work with: (a) equipment that produces ionising radiation; or (b) substances that emit ionising radiation; or (c) 2-naphthylamine; or (d) benzidine; or (e) cyclophosphamide; or (f) ortho-toluidine; or (g) polycyclic aromatic hydrocarbons during aluminium production. |
25 | Primary malignant disease of the brain | Employment for at least 5 years (whether consecutive or not) involving work with: (a) equipment that produces ionising radiation; or (b) substances that emit ionising radiation. |
26 | Primary malignant disease of the thyroid | Employment for at least 5 years (whether consecutive or not) involving work with: (a) equipment that produces ionising radiation; or (b) substances that emit ionising radiation. |
27 | Primary leukaemia (excluding chronic lymphatic leukaemia) | Employment for at least 2 years (whether consecutive or not) involving work with: (a) equipment that produces ionising radiation; or (b) substances that emit ionising radiation; or (c) benzene; or (d) butadiene; or (e) cyclophosphamide; or (f) formaldehyde. |
28 | Primary non-Hodgkins lymphoma | Employment for at least 2 years (whether consecutive or not) involving work with: (a) equipment that produces ionising radiation; or (b) substances that emit ionising radiation. |
Diseases of the nervous system |
29 | Parkinson’s disease | Employment for at least one year (whether consecutive or not) involving work with manganese. |
30 | Peripheral neuropathy | Employment for at least one year (whether consecutive or not) involving work with: (a) acrylamide; or (b) arsenic; or (c) carbon disulphide; or (d) lead; or (e) mercury; or (f) n-hexane; or (g) organophosphates; or (h) trichloroethylene. |
Respiratory diseases | |
31 | Occupational asthma | Employment for at least 4 weeks (whether consecutive or not) involving work with an agent or thing specified in column 2 of an item of the table in Schedule 2. |
32 | Coal workers’ pneumoconiosis | Employment for at least 5 years (whether consecutive or not) involving work with coal. |
33 | Asbestosis | Employment for at least 5 years (whether consecutive or not) involving work with: (a) asbestos; or (b) asbestos-containing material. |
34 | Silicosis | Employment for at least 5 years (whether consecutive or not) involving work with: (a) material containing crystalline silica; or (b) silica. |
35 | Other pneumoconiosis | Employment for at least 5 years (whether consecutive or not) involving work with: (a) aluminium; or (b) barium; or (c) beryllium; or (d) cobalt; or (e) iron oxide; or (f) tin; or (g) tungsten. |
36 | Byssinosis | Employment for at least 4 weeks (whether consecutive or not) involving work with: (a) unprocessed cotton; or (b) unprocessed flax; or (c) unprocessed hemp; or (d) unprocessed sisal. |
37 | Extrinsic allergic alveolitis | Employment for at least 4 weeks (whether consecutive or not) involving work with: (a) feathers; or (b) grain; or (c) hay; or (d) straw. |
Hepatic disease |
38 | Non-infectious hepatitis | Employment involving work with: (a) acrylonitrile; or (b) alcohols; or (c) amino-derivatives of benzene; or (d) antimony; or (e) aromatic hydrocarbons; or (f) arsenic; or (g) benzene; or (h) benzoquinone; or (i) beryllium; or (j) cadmium; or (k) carbon disulphide; or (l) carbon monoxide; or (m) chromium; or (n) copper; or (o) fluorine; or (p) glycols; or (q) hexane; or (r) hydrogen cyanide; or (s) hydrogen sulphide; or (t) ketones; or (u) lead; or (v) manganese; or (w) mercury; or (x) methylene chloride; or (y) mineral acids; or (z) nitric acid esters; or (za) organochlorine compounds; or (zb) organophosphate; or (zc) osmium; or (zd) oxides of nitrogen; or (ze) ozone; or (zf) phosgene; or (zg) phosphorus; or (zh) selenium; or (zi) styrene; or (zj) thallium; or (zk) tin; or (zl) toluene; or (zm) toxic halogen derivatives of aliphatic; or (zn) toxic nitro-derivatives of benzene; or (zo) vanadium; or (zp) zinc. |
Skin diseases | |
39 | Irritant contact dermatitis | Employment for at least 4 weeks (whether consecutive or not) involving work and contact with: (a) alcohols; or (b) cutting fluids; or (c) cleaners; or (d) degreasers; or (e) disinfectants; or (f) liquids (frequent contact); or (g) liquids (prolonged contact); or (h) petroleum products; or (i) soaps; or (j) solvents. |
40 | Allergic contact dermatitis | Employment for at least 4 weeks (whether consecutive or not) involving work and contact with: (a) 2,5-diaminotoluene sulfate; or (b) 4-phenylenediamine base; or (c) ammonium persulfate; or (d) cobalt chloride; or (e) cocamide diethanolamide; or (f) coconut diethanolamide; or (g) colophonium/colophony/rosin; or (h) diazolidinyl urea; or (i) epoxy resin; or (j) formaldehyde; or (k) fragrance mix I: (i) amylcinnamaldehyde; or (ii) cinnamic alcohol; or (iii) cinnamic aldehyde; (iv) eugenol; or (v) geraniol; or (vi) hydroxycitronellal; or (vii) isoeugenol; or (viii) oakmoss absolute; or (l) fragrance mix II: (i) citral; or (ii) citronellol; or (iii) coumarin; or (iv) farnesol; or (v) hexyl cinnamic aldehyde; or (vi) hydroxyisohexyl 3-cyclohexene carboxaldehyde; or (m) glyceryl monothioglycolate; or (n) hydroxyethyl methacrylate; or (o) mercaptobenzothiazole; or (p) methyl chloroisothiazolinone; or (q) mixture of methylchloroisothiazolinone and methylisothiazolinone; or (r) nickel sulfate; or (s) potassium dichromate; or (t) quaternium 15; or (u) thiuram mix: (i) tetramethylthiuramdisulfide; or (ii) tetramethylthiuram monosulfide; or (iii) tetraethylthiuram disulfide. |
41 | Occupational vitiligo | Employment for at least 4 weeks (whether consecutive or not) involving work with: (a) hydroquinone; or (b) monobenzyl ether of hydroquinone; or (c) monobutyl ether of hydroquinone; or (d) para-amylphenol; or (e) para-tertiary-butylcatechol; or (f) para-tertiary-butylphenol. |
Musculoskeletal diseases |
42 | Raynaud’s disease | Employment for at least 12 weeks (whether consecutive or not) involving work with: (a) powered equipment that produces vibration; or (b) powered tools that produce vibration. |
43 | Bursitis at the elbow or knee | Employment for at least 6 months (whether consecutive or not) involving a work activity that: (a) for bursitis at the elbow: (i) involves prolonged external friction at or about the elbow; or (ii) involves prolonged external pressure at or about the elbow; or (iii) involves recurrent external friction at or about the elbow; or (iv) involves recurrent external pressure at or about the elbow; or (b) for bursitis at the knee: (i) involves prolonged external friction at or about the knee; or (ii) involves prolonged external pressure at or about the knee; or (iii) involves recurrent external friction at or about the knee; or (iv) involves recurrent external friction at or about the knee. |
Acute diseases |
44 | Acute poisoning or toxicity affecting the heart, lungs, liver, kidney, nervous system or blood | The same as for item 38. |
| Column 1 | Column 2 |
Item | Class of agent or thing | Specified agent or thing |
1 | Arthropods | (a) acarian; or (b) barn mite; or (c) caddisfly; or (d) cricket; or (e) Ephestia kuehniella (Mediterranean flour moth); or (f) fowl mite; or (g) fruit fly; or (h) grain mite; or (i) flour mite; or (j) lesser mealworm; or (k) locust; or (l) sheep blowfly; or (m) silkworm. |
2 | Acids | (a) dodecanedioic acid; or (b) glacial acetic acid; or (c) hydrochloric acid; or (d) peroxyacetic acid; or (e) sulphuric acid; or (f) sulphur dioxide. |
3 | Acrylates | (a) acrylic acid; or (b) cyanoacrylates; or (c) methyl methacrylate; or (d) polymethyl methacrylate; or (e) trimethylolpropane triacrylate/2-hydroxypropyl acrylate. |
4 | Aldehydes | (a) formaldehyde; or (b) gluteraldehyde; or (c) paraformaldehyde; or (d) urea formaldehyde. |
5 | Amines | (a) aminoethyl ethanolamine; or (b) diethanolamine; or (c) dimethylethanolamine; or (d) ethanolamines; or (e) ethylenediamine; or (f) monoethanolamine; or (g) surfactant-specific amines; or (h) triethanolamine; or (i) triethylenetetramine; or (j) trimethylhexane-1; or (k) 6-diamine/isophorondiamine mixture. |
6 | Ammonias | (a) anhydrous ammonia; or (b) ammonium hydroxide; or (c) ammonia solution 10%; or (d) ammonia solution 29%. |
7 | Anhydrides | (a) hexahydrophthalic anhydride; or (b) himic anhydride; or (c) maleic anhydride; or (d) methyl tetrahydrophthalic; or (e) anhydride; or (f) phthalic anhydride; or (g) tetrachlorophthalic anhydride; or (h) trimellitic anhydride. |
8 | Bio-aerosols | (a) Alternaria; or (b) Chrysonilia sitophilia; or (c) Neurospora; or (d) Penicillium; or (e) cutting oils. |
9 | Biological enzymes | (a) Bacillus subtilis enzymes; or (b) bromelain; or (c) egg lysozyme; or (d) esperase; or (e) flaviastase; or (f) fungal amylase; or (g) fungal amyloglucosidase; or (h) fungal hemicellulose; or (i) pancreatin; or (j) papain; or (k) pepsin; or (l) trypsin. |
10 | Epoxy | (a) epoxy; or (b) epoxy adhesive. |
11 | Ethylene oxide | ethylene oxide. |
12 | Flours | (a) buckwheat flour; or (b) rye flour; or (c) soya flour; or (d) wheat flour. |
13 | Flowers | (a) baby’s breath; or (b) freesia; or (c) Limonium tataricum; or (d) sunflower. |
14 | Foods | (a) Brazil ginseng; or (b) castor bean; or (c) chamomile; or (d) cinnamon; or (e) Dioscorea batatas (Chinese yam); or (f) egg protein; or (g) fenugreek; or (h) garlic dust; or (i) green beans; or (j) guar; or (k) hops; or (l) paprika; or (m) pectin; or (n) rose hips; or (o) soybean lecithin; or (p) tea; or (q) thiamine (vitamin B); or (r) thyme. |
15 | Industrial cleaning and sterilising agents | (a) alkyl dimethyl benzyl ammonium chloride; or (b) benzyl-C10-16-alkyldimethyl, chlorides; or (c) benzyl-C12-16-alkyldimethyl, chlorides; or (d) benzyl-C12-18-alkyldimethyl, chlorides; or (e) benzyl-C16-18-alkyldimethyl, chlorides; or (f) benzyldimethylstearyl ammonium chloride; or (g) cetalkonium chloride; or (h) chlorhexidine; or (i) chlorine; or (j) dialkyl methyl benzyl ammonium chloride; or (k) dicumyl-peroxide; or (l) dodecyl dimethyl ammonium chloride; or (m) dimethyl ethyl benzyl ammonium chloride; or (n) dodecyl-dimethylbenzylammonium; or (o) fluorine; or (p) n-alkyl dimethyl benzyl ammonium chloride; or (q) persulphate salts; or (r) sodium hypochlorite; or (s) sodium metabisulfite. |
16 | Isocyanates | (a) diisocyanates; or (b) hexamethylene diisocyanate prepolymers; or (c) isocyanates; or (d) toluene diisocyanate prepolymers. |
17 | Latex | (a) latex; or (b) natural rubber. |
18 | Medications | (a) ampicillin; or (b) amprolium; or (c) cimetidine; or (d) codeine; or (e) colistin; or (f) hydralazine; or (g) ipecacuanha; or (h) hydrocodone; or (i) isonicotinic acid hydrazide; or (j) methyldopa; or (k) morphine; or (l) opiate compounds; or (m) oxycodone; or (n) papaverine; or (o) penicillamine; or (p) penicillins; or (q) phenylglycine acid chloride; or (r) psyllium; or (s) salbutamol intermediate; or (t) spiramycin; or (u) tetracycline; or (v) thebaine; or (w) tylosin tartrate; or (x) vancomycin. |
19 | Metals | (a) aluminium; or (b) aluminium chloride; or (c) aluminium oxide; or (d) aluminium compounds; or (e) ammonium dichromate; or (f) ammonium hexachloroplatinate (IV); or (g) chromium; or (h) chromium, metal; or (i) chromium, hexavalent; or (j) chromium, non-hexavalent; or (k) cobalt; or (l) cobalt compounds; or (m) nickel; or (n) nickel compounds; or (o) platinum; or (p) rhodium; or (q) soluble halogenated platinum compounds; or (r) titanium oxide/dioxide; or (s) tributyl tin oxide; or (t) tungsten carbide; or (u) tungsten carbide/cobalt; or (v) vanadium; or (w) welding fumes – gas metal arc welding on uncoated mild steel; or (x) welding fumes – stainless steel; or (y) stainless steel; or (z) zinc oxide. |
20 | Other reactive chemicals | (a) chlorofluorocarbon refrigerants heated; or (b) fluoride; or (c) furfuryl alcohol mixed with a catalyst; or (d) isolyzer; or (e) polyethylene terephthalate/polybutylene terephthal; or (f) polyfunctional aziridine; or (g) polypropylene heated; or (h) polyvinyl chloride heated; or (i) polyvinyl chloride non-heated; or (j) polyvinyl chloride thermally degraded; or (k) radiographic fixative; or (l) resin containing furfuryl alcohol; or (m) styrene; or (n) trigylicidyl isocyanurate. |
21 | Pesticides | (a) 3-amino-5-mercapto-1;2;4-triazole; or (b) acephate; or (c) chloramine T; or (d) chlorothalonil (bravo, echo); or (e) diazinon; or (f) dimethoate; or (g) fenthion; or (h) malathion; or (i) nemacur; or (j) piperazine; or (k) piperazine citrate; or (l) piperazine hydrochloride; or (m) pyrethrins; or (n) pyrfon; or (o) safrotin; or (p) tetramethrin. |
22 | Plants and sensitising agents or irritants derived from plants | (a) almond dust; or (a) Arabidopsis thaliana; or (b) Chlorella algae; or (c) gum arabic; or (d) henna; or (e) kapok; or (f) linseed oilcake; or (g) Pinellia ternata; or (h) quillaja bark; or (i) rice dust; or (j) tall oil crude; or (k) tall oil – rosin; or (l) tobacco leaf; or (m) tragacanth; or (n) turpentine; or (o) Vicia sativa (vetch); or (p) weeping fig. |
23 | Reactive dyes | (a) Cibachrome Brilliant Scarlet 32; or (b) Drimarene Brilliant Blue K-BL; or (c) Drimarene Brilliant Yellow K-3GL; or (d) Lanasol Yellow 4G; or (e) Levafix Brilliant Yellow E36; or (f) Methyl Blue; or (g) Rifacion Orange HE 2G; or (h) Rifafix Yellow 3 RN; or (i) Rifazol Black GR; or (j) Rifazol Brilliant Orange 3R. |
24 | Sensitising agents or irritants derived from animals | (a) bat guano; or (b) bovine serum albumin; or (c) casein; or (d) cat antigens; or (e) chicken antigens; or (f) cow antigens; or (g) frog antigens; or (h) guinea pig antigens; or (i) lactoserum; or (j) mice antigens; or (k) pig antigens; or (l) rabbit antigens; or (m) rat antigens. |
25 | Sensitising agents or irritants derived from fish or shellfish | (a) Anisakis simplex (herring worm) antigens; or (b) clam antigens; or (c) crab antigens; or (d) cuttlefish antigens; or (e) fishmeal; or (f) nacre dust; or (g) octopus antigens; or (h) prawn antigens; or (i) red soft coral antigens; or (j) salmon antigens; or (k) shrimp meal; or (l) trout antigens. |
26 | Soldering fluxes | (a) colophony soldering flux; or (b) alkyl aryl polyether soldering flux; or (c) zinc soldering flux. |
27 | Wood | (a) Triplochiton scleroxylon (African maple); or (b) Acacia melanoxylon (blackwood); or (c) Sequoia sempervirens (California redwood); or (d) Juglans olanchana (Central American walnut); or (e) Thuja occidentalis (eastern white cedar); or (f) Shoreal sp. (mahogany); or (g) Quercus robur (oak); or (h) Thuja lpicata (western red cedar). |